0241.HK
0241.HK
BMG0171K1018
ALI HEALTH
Loading chart...

Company Profile

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing, medical consultation, appointment-booking, physical examination, consultation, registration, vaccine, dentistry, psychology, optometry, and nursing services, as well as traditional chinese medicines. In addition, it engages in the digital tracking business; asset management; and operation of internet hospitals, as well as provision of network hospital, research, and Internet information services. Further, the company operates Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. It provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Taobao Instant Commerce, AMap, DingTalk, Freshippo, and Quark. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Related stocks

3391.T
3391.T • Japan
TSURUHA HOLDINGS INC
2,123.5 JPY
6.09B USD 1Y -13.5%
6618.HK
6618.HK • China
JD HEALTH
36.08 HKD
14.66B USD 1Y -43.4%
603939.SS
603939.SS • China
YIFENG PHARMACY CHAIN CO LTD
24.05 CNY
4.36B USD 1Y -2.2%
603233.SS
603233.SS • China
DASHENLIN PHARMACEUTICAL GROUP
18.76 CNY
3.2B USD 1Y +12.9%
7649.T
7649.T • Japan
SUGI HOLDINGS CO.LTD.
1,227.5 JPY
2.89B USD 1Y -27.4%
3088.T
3088.T • Japan
MATSUKIYOCOCOKARA & CO
2,476.5 JPY
6.16B USD 1Y -15.2%
3349.T
3349.T • Japan
COSMOS PHARMACEUTICAL CORP
6,392 JPY
3.2B USD 1Y -23.8%
9989.T
9989.T • Japan
SUNDRUG CO LTD
3,530 JPY
2.61B USD 1Y -16.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
63.3% p.a.
Max Drawdown (5Y)
-79.3%
Sharpe Ratio (5Y)
-0.42
Beta Factor
1.58
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.58 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (63.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -91.3% in the extended horizon.
ende